Your browser doesn't support javascript.
loading
Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
Beck, Jérémie; Rouleau, Mélanie; Lemire, Francis; Neveu, Bertrand; Déry, Michel; Thériault, Benoît; Dubois, Gabriel; Guérette, Dominique; Pouliot, Frédéric.
Afiliação
  • Beck J; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Rouleau M; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Lemire F; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Neveu B; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Déry M; Biochemistry Service, Medical Laboratory Department, CHU de Québec-Université Laval, Québec, Québec, Canada.
  • Thériault B; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Dubois G; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
  • Guérette D; Biochemistry Service, Medical Laboratory Department, CHU de Québec-Université Laval, Québec, Québec, Canada.
  • Pouliot F; Division of Urology, Department of Surgery and Cancer Research Center, Faculty of Medicine, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada.
Prostate ; 83(7): 670-677, 2023 05.
Article em En | MEDLINE | ID: mdl-36851864

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá